Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Releases AirDuo RespiClick plus Generic for Asthma | RT
Teva Announces FDA approval of AirDuo® Digihaler™
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals releases its prescription ProAir Digihaler in the US | MobiHealthNews
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva's Advair rival joins the hopefuls gunning for GSK's blockbuster sales | Fierce Pharma
Teva Launches 2 New Digital Maintenance Inhalers
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire
Teva Inhalation Aerosol Approved by FDA for Children 4 and Over - Pharmaceutical Processing World
FDA Approves Teva's ProAir Digihaler for Asthma, COPD | RT
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
How Teva Is Leveraging IBM Watson To Improve Healthcare
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceutical Gets a Taste of Its Own Medicine As the FDA Approves a Generic of Its Asthma Drug | The Motley Fool
Anything but Generic: A map for Selling to Teva Pharmaceuticals
